Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002171-29Phase 4Terminated
Phase 4, randomised trial in coronary arteriosclerosis, unstable angina and stable angina comparing Prasugrel intensified loading with Clopidogrel high-dose loading (2 arms). Primary endpoint: Composite ischemic outcome at 30 days. Started Apr 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002171-29.